Recent Antibody Technologies Research for January 2025
Antibody Drug Conjugates Contract Manufacturing Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
Topics: Antibody Technologies, COVID-19/Coronavirus
| Global Antibody Drug Conjugates (ADC); By Type (Cleavable Linker and Non-cleavable Linker), By Application (Blood Cancer (Leukemia, Multiple Myeloma, Lymphoma, Breast Cancer, Urothelial Cancer & Bladder Cancer and Others), By End Users (Research Institute
Topics: Antibody Technologies, Cancer Treatment, Hospitals & Clinics, Women's Health, Oncology/Hematology
Regions: Africa, Asia, Europe, North America, Oceania, South America, Global
| Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
Topics: Antibody Technologies, Biomarkers, Molecular Diagnostics, Biopharmacology, Manufacturing, Packaging & Detailing, Research & Development, Drug Discovery
Regions: Global
| South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infecti
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Central America
| Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Africa, Middle East
| Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), By Technology (Cleavable, Non-cleavable Linker, Linkerless), And Segment Forecasts, 2022 - 2030
Topics: Antibody Technologies, Cancer Treatment, Oncology/Hematology
| Middle East and Turkey Chronic Liver Disease (CLD) Therapeutics Market, by Disease Type (Hepatitis, Alcohol Induced Liver Disease, Liver Cancer, Fatty Liver Disease, and Others), by Drug Class (Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobuli
Topics: Antibody Technologies, Hepatitis, Cancer Treatment, Hospitals & Clinics, Vaccines, Drug Discovery, Clinical Nutrition
Regions: Egypt, Turkey, Israel, Saudi Arabia, United Arab Emirates, Middle East
| Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products (Kits, Chemical & reagents, and Consumables), Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases
Topics: Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Infectious Diseases
Regions: Global
| Acetaminophen Reagents Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product (Antibody/Substrate Reagent, Enzyme Reagent, Acetaminophen Antiserum, Acetaminophen Fluorescein Tracer, and Pretreatment Solution), Application (Enzymatic As
Topics: Enzymes, Antibody Technologies, COVID-19/Coronavirus, Laboratories, Immunoassays, Point-of-Care
Regions: Global
| Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragme
Topics: Biosimilars, Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Oncology/Hematology
Regions: Global
| Global Guillain-Barre Syndrome Treatment Market - 2022-2029
Topics: Antibody Technologies, Autoimmune
Regions: Global
| North America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus
Regions: North America
| North America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies
Topics: Biosimilars, Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Hematology & Oncology
Regions: North America
| Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Di
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases, Oncology/Hematology
Regions: Global
| Global Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025
Topics: Biosimilars, Antibody Technologies
Regions: Global
| Tissue Diagnostics: Technologies and Global Markets
Topics: Antibody Technologies, Histology & Cytology, General In Vitro Diagnostics, Molecular Diagnostics
Regions: Global
| Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
Topics: Antibody Technologies, COVID-19/Coronavirus
| Global Cancer Monoclonal Antibodies Market Analysis 2021
Topics: Antibody Technologies, Cancer Treatment, Oncology/Hematology
Regions: Global
| Asia Pacific Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service (Antibody Development, Antibody Production and Purification, and Antibody Fragmentation and Labelling); Type (Monoclonal Antibodies, Polyclonal Antibod
Topics: Antibody Technologies, Stem Cell, COVID-19/Coronavirus, Infectious Diseases, Oncology/Hematology
Regions: Asia, Oceania
| Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Antibody Technologies, COVID-19/Coronavirus
Regions: Global
| Antibody Therapy Market Size By Type (Monoclonal Antibodies [mAbs] {Oncology, Autoimmune Diseases, Infectious Diseases}, Antibody-drug Conjugates [ADCs]), By End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potent
Topics: Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Hematology & Oncology, Infectious Diseases, Oncology/Hematology
| Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Reagents, Kits), By Application (Diagnostics, Drug Testing), By End Use, By Region, And Segment Forecasts, 2021 - 2028
Topics: Antibody Technologies
Regions: Global
| Antibody Drug Conjugates Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Antibody Technologies, COVID-19/Coronavirus
| Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), & End User - Global Forecast to 2025
Topics: Research & Development, Antibody Technologies, COVID-19/Coronavirus, Research & Development
Regions: Global
| Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026
Topics: Antibody Technologies, Cancer Treatment, Immunoassays, Research & Development, Infectious Diseases
Regions: Global
| Asia Pacific Generic Oncology Sterile Injectable Market, by Drug Type (Monoclonal Antibodies, Chemotherapy (Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, and Others), Cytokines, and Peptide Hormones), by Disease Indication (O
Topics: Antibody Technologies, Cancer Treatment, Hospitals & Clinics, Needles, Syringes, IV Access, Generics Drugs, Pharmacy & Distribution, Antibiotic, Drug Stores, Oncology/Hematology
Regions: China, India, Japan, South Korea, Australia, Asia, Oceania
| Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast -2032
Topics: Antibody Technologies, Needles, Syringes, IV Access, Pharmaceuticals Company Reports, Drug Discovery, Clinical Trial
| Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032
Topics: Research & Development, Antibody Technologies
| Anti GM-CSF Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies, Drug Discovery
| Anti-CD19 Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies, Drug Discovery
| Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies, Drug Discovery
| Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies, Drug Discovery
| Anti-CD28 Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies, Drug Discovery
| Anti-CD80 Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies
| Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies
| Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
Topics: Antibody Technologies
| Next-Generation Biomanufacturing Market - A Global Analysis: Focus on Single-Use and Digital Platform and Segment Analysis for Workflow, Products, Medical Application, End User, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecas
Topics: Biosimilars, Antibody Technologies, Drug Development, Cancer Vaccines, Pandemic Vaccines
Regions: Global
| Global Electroporation Instruments Market 2021-2025
Topics: Biosimilars, General Biotechnology, Antibody Technologies
Regions: Global
| Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Biosimilars, Antibody Technologies, COVID-19/Coronavirus
Regions: Global
| HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive / Terminated / Withdrawn Biosimilars, Industry / Non-Industry Partnerships
Topics: Biosimilars, Antibody Technologies, Crohn's, Research & Development, Clinical Trial
| Protein Expression Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Competent Cells, Expression Vectors, Reagents and Instruments); Services (Antibody Development & Production, Protein Expression & Production, Hybridoma One-Stop S
Topics: Genomics, Proteomics, Antibody Technologies, Cell Culture, COVID-19/Coronavirus
Regions: Global
| Immunology Market, by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others), by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammat
Topics: Antibody Technologies, Arthritis, Psoriasis, Hospitals & Clinics, Drug Stores, E-Commerce & Online Retailing, Allergy/Immunology, Rheumatology/Arthritis
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America
| Immunohistochemistry Market Report: Trends, Forecast and Competitive Analysis
Topics: Antibody Technologies, Cancer Treatment, Autoimmune
| Large Molecule Bioanalytical Testing Service Market Report: Trends, Forecast and Competitive Analysis
Topics: Antibody Technologies
| Biopharmaceutical Fermentation System Market Report: Trends, Forecast and Competitive Analysis
Topics: Antibody Technologies, Biologics, Biopharmaceuticals
| Diagnostic Specialty Antibody Market Report: Trends, Forecast and Competitive Analysis
Topics: Antibody Technologies
| HER2 Antibody Market Report: Trends, Forecast and Competitive Analysis
Topics: Antibody Technologies
| Gene Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030Including: 1) By Gene Type: Antigen; Cytokine; Suicide Gene; Others2) By Vector: Viral Vector; Non-Viral Vector; Others3) By Application: Oncological Disorders; Rare Diseases; Cardi
Topics: Gene Therapy, Antibody Technologies, Stem Cell, COVID-19/Coronavirus, Hospitals & Clinics, Drug Discovery, Cardiovascular, Infectious Diseases
Regions: Global
| Immunomodulators Market, by Product Type (Immunosuppressants (Calcineurin Inhibitors, Glucocorticoids, Antimetabolites, and Others), Immunostimulants (Vaccines, Antibodies, and Others)), by Application (Oncology, Respiratory, HIV, and Others), by End User
Topics: Antibody Technologies, AIDS, HIV & STDs, Hospitals & Clinics, Manufacturing, Packaging & Detailing, Research & Development, Vaccines, Respiratory/Pulmonary
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America
| Investigation Report on China's Omalizumab Market 2021-2025
Topics: Antibody Technologies
Regions: China
|
Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
